Arrowhead Pharmaceuticals Presents Preclinical Data on ARO-ALK7 for Treatment of Obesity
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced preclinical results on ARO-ALK7, the company’s investigational RNA interference (RNAi) therapeutic targeting Activin receptor-like kinase ...
Eupraxia Pharmaceuticals Announces Positive Data from RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis
Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology ...
3 Ways Life Sciences Can Benefit From Open-Source AI
Open-source AI can reshape the industry landscape, making advanced AI capabilities more accessible to organizations of all ...
Science Daily19h
Massive data analysis advances the understanding of how immunotherapy works
Researchers identify predictive markers of response to immunotherapy treatment in a study involving data from over 700 patients across six different cohorts. The study has significant relevance, ...
American Association of Individual Investors21h
Which Is a Better Investment, Clearwater Analytics Holdings, Inc. or Teradata Corporation Stock?
Learn more about whether Clearwater Analytics Holdings, Inc. or Teradata Corporation is a better investment based on AAII's ...